ALKERMES reported 1.05B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Amgen AMGN:US $ 24380M 5281M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Gilead Sciences GILD:US $ 14200M 275M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
H. Lundbeck A/S LUN:DC 9.13B 987M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Minerva Neurosciences NERV:US $ 67.44M 7.79M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Otsuka Holdings 4578:JP Y 1064063M 13729M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Zogenix ZGNX:US $ 375.46M 40.93M